首页> 美国卫生研究院文献>Nucleic Acids Research >Quantification of mRNA expression by competitive PCR using non-homologous competitors containing a shifted restriction site
【2h】

Quantification of mRNA expression by competitive PCR using non-homologous competitors containing a shifted restriction site

机译:定量mRNA表达 通过竞争PCR使用非同源竞争者 限制位点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the recent introduction of real-time PCR methods, competitive PCR techniques continue to play an important role in nucleic acid quantification because of the significantly lower cost of equipment and consumables. Here we describe a shifted restriction-site competitive PCR (SRS-cPCR) assay based on a modified type of competitor. The competitor fragments are designed to contain a recognition site for a restriction endonuclease that is also present in the target sequence to be quantified, but in a different position. Upon completion of the PCR, the amplicons are digested in the same tube with a single restriction enzyme, without the need to purify PCR products. The generated competitor- and target-specific restriction fragments display different sizes, and can be readily separated by electrophoresis and quantified by image analysis. Suboptimal digestion affects competitor- and target-derived amplicons to the same extent, thus eliminating the problem of incorrect quantification as a result of incomplete digestion of PCR products. We have established optimized conditions for a panel of 20 common restriction endonucleases permitting efficient digestion in PCR buffer. It is possible, therefore, to find a suitable restriction site for competitive PCR in virtually any sequence of interest. The assay presented is inexpensive, widely applicable, and permits reliable and accurate quantification of nucleic acid targets.
机译:尽管最近引入了实时PCR方法,但是竞争性PCR技术仍在核酸定量中起着重要作用,因为设备和消耗品的成本大大降低。在这里,我们描述了一种基于竞争者改良型的移动限制性位点竞争PCR(SRS-cPCR)分析方法。竞争片段设计为包含限制性核酸内切酶的识别位点,该核酸也存在于待量化的靶序列中,但位置不同。 PCR完成后,无需纯化PCR产物,即可在同一试管中用单一限制酶消化扩增子。产生的竞争者和目标特异性限制片段显示不同的大小,可以很容易地通过电泳分离并通过图像分析进行定量。次优消化对竞争者和靶标扩增子的影响程度相同,从而消除了由于PCR产物消化不完全而导致定量错误的问题。我们为20种常见的限制性内切核酸酶建立了优化条件,以确保高效 在PCR缓冲液中消化。因此,有可能找到合适的限制 几乎可以按照任何感兴趣的顺序进行竞争性PCR的位点。 提出的测定法价格便宜,适用范围广并且允许 可靠,准确地定量核酸靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号